In partnership with
🔬TODAY’S BREAKTHROUGH
Scientists have uncovered a surprising role for a long noncoding RNA in controlling how senescent cells manage energy and stress.
The Discovery:
Researchers identified sin-lncRNA, a noncoding RNA that becomes highly active in senescent cells. By binding to the enzyme DLST, it keeps mitochondria working and prevents runaway oxidative stress. Without it, cells shift metabolism, increase damage, and reinforce aging traits.
The Science:
sin-lncRNA is induced by C/EBPβ during senescence and localizes to mitochondria.
It anchors DLST, a key enzyme of the TCA cycle, preventing its relocation to the nucleus.
Loss of sin-lncRNA impairs oxidative phosphorylation, lowers oxygen consumption, and forces cells toward glycolysis.
This shift raises reactive oxygen species (ROS), reinforcing the senescent state.
In ovarian cancer cells treated with cisplatin, sin-lncRNA rises; its depletion reduces mitochondrial activity and makes tumors more drug-sensitive.
Your Action:
This is early mechanistic research, but it shows how noncoding RNAs can shape aging at the metabolic level.
Support mitochondrial health through balanced nutrition, exercise, and stress reduction, strategies known to lower oxidative stress while science works toward RNA-based therapies.
Bottom Line:
A newly discovered RNA keeps senescent cells’ metabolism in check, its disruption worsens aging traits and impacts cancer therapy.
Source:
A lncRNA-mediated metabolic rewiring of cell senescence. Cell Reports. Grossi E, Marchese FP, Montes M, Huarte M.
https://doi.org/10.1016/j.celrep.2025.115747
How was today’s newsletter?
A Quick Favor:
We kindly ask you to check out the sponsor(s) that made this newsletter possible. Your support helps us continue sharing valuable insights and empowering your wellness journey.
Keep This Stock Ticker on Your Watchlist
They’re a private company, but Pacaso just reserved the Nasdaq ticker “$PCSO.”
No surprise the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. What is unique is Pacaso is giving the same opportunity to everyday investors. And 10,000+ people have already joined them.
Created a former Zillow exec who sold his first venture for $120M, Pacaso brings co-ownership to the $1.3T vacation home industry.
They’ve generated $1B+ worth of luxury home transactions across 2,000+ owners. That’s good for more than $110M in gross profit since inception, including 41% YoY growth last year alone.
And you can join them today for just $2.90/share. But don’t wait too long. Invest in Pacaso before the opportunity ends September 18.
Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.
LEARN MORE ABOUT OUR WORK
— Capilli Eternal
Disclaimer:
This newsletter is for informational purposes only and does not substitute professional medical advice. Always consult with a healthcare provider before making any changes to your health regimen.